Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.6B | 3.5B | 3.5B | 3.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 673M | 630M | 657M | 686M |
Operating income | 1.2B | 1.3B | 1.3B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 17M | 18M | 19M | 20M |
Other income expense | — | — | — | — |
Pretax income | 2.2B | 1.6B | 1.8B | 1.5B |
Tax provision | 375M | 380M | 422M | 374M |
Net income | 1.8B | 1.2B | 1.4B | 1.1B |
Basic EPS | — | 20.2 | 22.5 | 19 |
Diluted EPS | — | 20.1 | 22.5 | 19.0 |
Basic average shares | — | 60.0M | 59.9M | 60M |
Diluted average shares | — | 60.1M | 60.1M | 60.1M |
EBITDA | 2.3B | 1.7B | 1.9B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |